Variant report
Variant | esv2761378 |
---|---|
Chromosome Location | chr7:146343685-146344283 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34825114 | chr7:146343691-146343692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537113913 | chr7:146343692-146343693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532543441 | chr7:146343714-146343715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557093595 | chr7:146343717-146343718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573837233 | chr7:146343749-146343750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542850578 | chr7:146343778-146343779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552992749 | chr7:146343798-146343799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547627113 | chr7:146343866-146343867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150715728 | chr7:146343875-146343876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530286982 | chr7:146343924-146343925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548887643 | chr7:146343942-146343943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576712550 | chr7:146343967-146343968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74971693 | chr7:146343988-146343989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530835011 | chr7:146344012-146344013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544253547 | chr7:146344045-146344046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138105289 | chr7:146344094-146344095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530227940 | chr7:146344103-146344104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10258848 | chr7:146344105-146344106 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs543951281 | chr7:146344192-146344193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190037268 | chr7:146344198-146344199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552614813 | chr7:146344228-146344229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552682955 | chr7:146344248-146344249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571212128 | chr7:146344280-146344281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10262146 | chr7:146344283-146344284 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Epilepsy | 20502679 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:146342400-146345400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr7:146342600-146345200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr7:146342800-146344000 | Weak transcription | Pancreas | Pancrea |
4 | chr7:146343400-146348800 | Weak transcription | Primary hematopoietic stem cells | blood |
5 | chr7:146343600-146345200 | Enhancers | Fetal Thymus | thymus |
6 | chr7:146344000-146344200 | Enhancers | Pancreas | Pancrea |
7 | chr7:146344200-146345000 | Weak transcription | Pancreas | Pancrea |